There were 747 press releases posted in the last 24 hours and 313,169 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image